Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Fast track designation for rhC1INH in hereditary angioedema

July 31, 2006

New phase II study for Genz-112638 in Gaucher's disease

July 28, 2006

Xechem accelerates construction of Nicosan production facility

July 28, 2006

Liponex prepares for phase I/II study of CRD-5 for dyslipidemia

July 28, 2006

NCX-4016 to be advanced as insulin sensitizing agent for type 2 diabetes

July 28, 2006

Meiji Seika signs license agreement for progesterone modulator with Tokai

July 28, 2006

Withania somnifera improves muscle strength in elderly subjects

July 28, 2006

Kos reports findings from flush provocation study of Niaspan CF with aspirin

July 28, 2006

Once-weekly alendronate sodium hydrate products approved in Japan

July 27, 2006

Org-36286 enters phase III in treatment of infertility

July 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...